WASHINGTON, March 7 -- The Senate Special Committee on Aging released the following written testimony by Bradley Campbell, president and CEO of Amicus Therapeutics Inc., Princeton, New Jersey, and a board member of the Biotechnology Innovation Organization, from a Feb. 26, 2026, hearing entitled "From Regulator to Roadblock: How FDA Bureaucracy Stifles Innovation." FDA is the Food and Drug Administration.

* * *

Chairman Scott, Ranking Member Gillibrand, and di . . .

Click here for more information about our products